Rights issue in Medivir AB (SE) – SEK 151 million

DNB Carnegie acted as Joint Bookrunner in the fully guaranteed rights issue of SEK 151 million in Medivir.
Medivir is a pharmaceutical company focusing on the development of innovative treatments for cancer in areas of high unmet medical need